Antibiofilm activity of nanosized magnesium fluoride.
The ability of bacteria to develop antibiotic resistance and colonize abiotic surfaces by forming biofilms is a major cause of medical implant-associated infections and results in prolonged hospitalization periods and patient mortality. This raises the urgent need to develop compounds that can inhibit bacterial colonization of surfaces. In this study, we present an unreported microwave-based synthesis of MgF(2) nanoparticles (Nps) using ionic liquid. We demonstrate the antimicrobial activity of these fluoride nanomaterials and their ability to restrict biofilm formation of common bacterial pathogens. Scanning and transmission electron microscopic techniques indicated that the MgF(2).Nps attach and penetrate into the cells. Flow cytometry analysis revealed that the Nps caused a disruption in the membrane potential. The MgF(2).Nps also induced membrane lipid peroxidation and once internalized can interact with chromosomal DNA. Based on these findings we further explored the possibility of using the MgF(2).Nps to coat surfaces and inhibit biofilm formation. A microwave synthesis and coating procedure was utilized to coat glass coupons. The MgF(2) coated surfaces effectively restricted biofilm formation of the tested bacteria. Taken together these results highlight the potential for developing MgF(2) nanoparticles in order to inhibit bacterial infections.
Lellouche
Jonathan
J
The Mina and Everard Goodman Faculty of Life Sciences, The Institute for Advanced Materials and Nanotechnology, Bar-Ilan University, Ramat-Gan, Israel.
Kahana
Edith
E
Elias
Sivan
S
Gedanken
Aharon
A
Banin
Ehud
E
D000900:Anti-Bacterial Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D001672:Biocompatible Materials; D018441:Biofilms; D002875:Chromosomes / Q000378:metabolism; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000378:metabolism; D005434:Flow Cytometry / Q000379:methods; D005459:Fluorides / Q000737:chemistry* / Q000494:pharmacology*; D015227:Lipid Peroxidation; D017616:Magnesium Compounds / Q000737:chemistry* / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D008855:Microscopy, Electron, Scanning / Q000379:methods; D046529:Microscopy, Electron, Transmission / Q000379:methods; D053758:Nanoparticles / Q000737:chemistry*; D036103:Nanotechnology / Q000379:methods*; D013211:Staphylococcus aureus / Q000378:metabolism; D013499:Surface Properties
D000900:Anti-Bacterial Agents; D001672:Biocompatible Materials; D017616:Magnesium Compounds; C031288:magnesium fluoride; D005459:Fluorides